300813 泰林生物
已收盘 10-08 15:00:00
资讯
新帖
简况
泰林生物（300813）披露取得5项专利证书公告，9月30日股价上涨2.33%
证券之星 · 09-30
泰林生物（300813）披露取得5项专利证书公告，9月30日股价上涨2.33%
股市必读：泰林生物新发布《关于设立新加坡孙公司并完成注册登记及境外投资项目备案的公告》
证券之星 · 09-28
股市必读：泰林生物新发布《关于设立新加坡孙公司并完成注册登记及境外投资项目备案的公告》
泰林生物（300813）披露关于2026年员工持股计划非交易过户完成暨回购股份处理完成的公告，9月24日股价下跌2.63%
证券之星 · 09-24
泰林生物（300813）披露关于2026年员工持股计划非交易过户完成暨回购股份处理完成的公告，9月24日股价下跌2.63%
股市必读：泰林生物新发布《第四届董事会第十七次会议决议公告》
证券之星 · 09-23
股市必读：泰林生物新发布《第四届董事会第十七次会议决议公告》
泰林生物（300813）披露关于调整2026年员工持股计划购买价格的议案，9月22日股价上涨2.39%
证券之星 · 09-22
泰林生物（300813）披露关于调整2026年员工持股计划购买价格的议案，9月22日股价上涨2.39%
泰林生物（300813）披露2026年半年度利润分配方案获临时股东会审议通过，9月14日股价下跌0.89%
证券之星 · 09-14
泰林生物（300813）披露2026年半年度利润分配方案获临时股东会审议通过，9月14日股价下跌0.89%
股市必读：泰林生物新发布《国浩律师（杭州）事务所关于浙江泰林生物技术股份有限公司2026年第二次临时股东会法律意见书》
证券之星 · 09-14
股市必读：泰林生物新发布《国浩律师（杭州）事务所关于浙江泰林生物技术股份有限公司2026年第二次临时股东会法律意见书》
股市必读：泰林生物新发布《2026年半年度报告》
证券之星 · 08-28
股市必读：泰林生物新发布《2026年半年度报告》
泰林生物（300813）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 08-28
泰林生物（300813）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大
股市必读：泰林生物中报 - 第二季度单季净利润同比增长55.10%
证券之星 · 08-27
股市必读：泰林生物中报 - 第二季度单季净利润同比增长55.10%
泰林生物(300813)6月30日股东户数1.09万户，较上期减少30.1%
证券之星 · 08-26
泰林生物(300813)6月30日股东户数1.09万户，较上期减少30.1%
泰林生物(300813.SZ)发布上半年业绩，归母净利润2037.28万元，同比增长50.43%
智通财经 · 08-26
泰林生物(300813.SZ)发布上半年业绩，归母净利润2037.28万元，同比增长50.43%
泰林生物终止发不超2.3亿可转债 为长城证券保荐项目
中金财经 · 08-17
泰林生物终止发不超2.3亿可转债 为长城证券保荐项目
股市必读：泰林生物新发布《关于终止向不特定对象发行可转换公司债券并撤回申请文件的公告》
证券之星 · 08-17
股市必读：泰林生物新发布《关于终止向不特定对象发行可转换公司债券并撤回申请文件的公告》
股市必读：泰林生物新发布《关于取得专利证书的公告》
证券之星 · 08-10
股市必读：泰林生物新发布《关于取得专利证书的公告》
泰林生物（300813）披露取得发明专利证书公告，8月7日股价上涨2.57%
证券之星 · 08-07
泰林生物（300813）披露取得发明专利证书公告，8月7日股价上涨2.57%
股市必读：泰林生物（300813）新发布《关于取得专利证书及计算机软件著作权登记证书的公告》
证券之星 · 07-31
股市必读：泰林生物（300813）新发布《关于取得专利证书及计算机软件著作权登记证书的公告》
股市必读：泰林生物（300813）7月14日董秘有最新回复
证券之星 · 07-15
股市必读：泰林生物（300813）7月14日董秘有最新回复
泰林生物：TOC总有机碳分析仪可应用于超纯水
证券之星 · 07-14
泰林生物：TOC总有机碳分析仪可应用于超纯水
泰林生物不超2.3亿元可转债被暂缓审议 长城证券保荐
中金财经 · 07-14
泰林生物不超2.3亿元可转债被暂缓审议 长城证券保荐
加载更多
公司概况
公司名称：
浙江泰林生物技术股份有限公司
所属行业：
专用设备制造业
上市日期：
2020-01-14
主营业务：
浙江泰林生物技术股份有限公司的主营业务是无菌生产与污染控制设备、微生物检测及有机物分析等产品的研发、生产和销售。公司的主要产品是无菌生产与污染控制设备系列产品、微生物检测技术系列产品、有机物分析技术系列产品。
发行价格：
18.35
{"stockData":{"symbol":"300813","market":"SZ","secType":"STK","nameCN":"泰林生物","latestPrice":23.22,"timestamp":1791442992000,"preClose":22.83,"halted":0,"volume":4852100,"delay":0,"changeRate":0.0171,"floatShares":85126100,"shares":121000000,"eps":0.1924,"marketStatus":"已收盘","change":0.39,"latestTime":"10-08 15:00:00","open":23.01,"high":23.68,"low":22.6,"amount":112000000,"amplitude":0.0473,"askPrice":23.22,"askSize":42,"bidPrice":23.2,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.1924,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791509400000},"marketStatusCode":5,"adr":0,"adjPreClose":22.83,"symbolType":"stock","openAndCloseTimeList":[[1791423000000,1791430200000],[1791435600000,1791442800000]],"highLimit":25.11,"lowLimit":20.55,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":121199219,"isCdr":false,"pbRate":3.5,"roa":"--","peRate":120.686071,"roe":"2.53%","epsLYR":0.14,"committee":-0.391667,"marketValue":2814000000,"turnoverRate":0.057,"status":0,"floatMarketCap":1977000000},"requestUrl":"/m/hq/s/300813","defaultTab":"news","newsList":[{"id":"2671320880","title":"泰林生物（300813）披露取得5项专利证书公告，9月30日股价上涨2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671320880","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671320880?lang=zh_cn&edition=full","pubTime":"2026-09-30 17:39","pubTimestamp":1790761184,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，泰林生物报收于22.83元，较前一交易日上涨2.33%，最新总市值为27.67亿元。该股当日开盘22.45元，最高23.46元，最低22.29元，成交额达9174.59万元，换手率为4.67%。近日，浙江泰林生物技术股份有限公司全资子公司泰林生命科学、泰林医学工程、泰林分析仪器取得5项专利证书，包括一种VHP管路保温装置、一种便于排液的密封进样装置、底座自动上料装置以及台式滚压轧盖机和台式轧盖机两项外观设计专利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000028336.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670798409","title":"股市必读：泰林生物新发布《关于设立新加坡孙公司并完成注册登记及境外投资项目备案的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2670798409","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670798409?lang=zh_cn&edition=full","pubTime":"2026-09-28 02:27","pubTimestamp":1790533631,"startTime":"0","endTime":"0","summary":"公司公告汇总关于设立新加坡孙公司并完成注册登记及境外投资项目备案的公告浙江泰林生物技术股份有限公司通过全资子公司浙江泰林科学技术有限公司以自有资金在新加坡设立全资孙公司TAILIN BIOENGINEERING SINGAPORE PTE. LTD.，注册资本10万新币，已完成注册登记，并取得浙江省发展和改革委员会的境外投资项目备案通知书。新设孙公司纳入合并报表范围，不会对公司本年度财务结构及运营造成不利影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800001250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","STmain","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669496074","title":"泰林生物（300813）披露关于2026年员工持股计划非交易过户完成暨回购股份处理完成的公告，9月24日股价下跌2.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669496074","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669496074?lang=zh_cn&edition=full","pubTime":"2026-09-24 22:20","pubTimestamp":1790259629,"startTime":"0","endTime":"0","summary":"近日，浙江泰林生物技术股份有限公司发布《关于2026年员工持股计划非交易过户完成暨回购股份处理完成的公告》。公告显示，公司于2026年9月23日完成2026年员工持股计划的非交易过户，将回购专用证券账户中持有的1,217,970股公司股票过户至员工持股计划账户，占公司总股本的1.00%，过户价格为14.00元/股。本次非交易过户完成后，回购专用证券账户持股数量为0股，回购股份已全部用于员工持股计划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400041226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669219781","title":"股市必读：泰林生物新发布《第四届董事会第十七次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669219781","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669219781?lang=zh_cn&edition=full","pubTime":"2026-09-23 02:36","pubTimestamp":1790102170,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘，泰林生物报收于23.15元，上涨2.39%，换手率4.27%，成交量3.64万手，成交额8311.17万元。公司公告汇总第四届董事会第十七次会议决议公告浙江泰林生物技术股份有限公司于2026年9月22日召开第四届董事会第十七次会议，审议通过《关于调整2026年员工持股计划购买价格的议案》。董事夏信群、沈志林、倪小璐作为本次员工持股计划参与对象，对议案回避表决。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669112886","title":"泰林生物（300813）披露关于调整2026年员工持股计划购买价格的议案，9月22日股价上涨2.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669112886","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669112886?lang=zh_cn&edition=full","pubTime":"2026-09-22 22:22","pubTimestamp":1790086938,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘，泰林生物报收于23.15元，较前一交易日上涨2.39%，最新总市值为28.06亿元。公司于当日发布《第四届董事会第十七次会议决议公告》，审议通过《关于调整2026年员工持股计划购买价格的议案》。因2026年半年度权益分派实施，公司将2026年员工持股计划的股票购买价格由14.10元/股调整为14.00元/股。董事夏信群、沈志林、倪小璐作为本次员工持股计划参与对象，对议案回避表决。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200041823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667110652","title":"泰林生物（300813）披露2026年半年度利润分配方案获临时股东会审议通过，9月14日股价下跌0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667110652","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667110652?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:53","pubTimestamp":1789379585,"startTime":"0","endTime":"0","summary":"截至2026年9月14日收盘，泰林生物报收于20.12元，较前一交易日下跌0.89%，最新总市值为24.39亿元。近日，浙江泰林生物技术股份有限公司发布《2026年第二次临时股东会决议公告》。公告显示，公司于2026年9月11日召开2026年第二次临时股东会，出席会议的股东共50人，代表股份53,776,028股，占公司有表决权股份总数的44.8204%。会议审议通过了《关于2026年半年度利润分配方案的议案》，中小股东对该议案的同意股数占比为96.9698%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400024216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667316638","title":"股市必读：泰林生物新发布《国浩律师（杭州）事务所关于浙江泰林生物技术股份有限公司2026年第二次临时股东会法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2667316638","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667316638?lang=zh_cn&edition=full","pubTime":"2026-09-14 03:05","pubTimestamp":1789326316,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，泰林生物报收于20.3元，下跌0.68%，换手率2.77%，成交量2.36万手，成交额4688.85万元。公司公告汇总：泰林生物于2026年9月11日召开第二次临时股东会，审议通过2026年半年度利润分配方案，中小股东同意股数占比96.9698%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400001226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031101","title":"股市必读：泰林生物新发布《2026年半年度报告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031101","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662031101?lang=zh_cn&edition=full","pubTime":"2026-08-28 07:32","pubTimestamp":1787873535,"startTime":"0","endTime":"0","summary":"截至2026年8月27日收盘，泰林生物报收于21.43元，上涨4.54%，换手率6.36%，成交量5.41万手，成交额1.16亿元。公司公告汇总：2026年半年度营业收入同比增长13.41%，归母净利润同比增长50.43%，经营性现金流同比大增576.15%。该方案尚需提交2026年第二次临时股东大会审议。关于2026年半年度报告披露的提示性公告2026年半年度报告已于2026年8月27日在巨潮资讯网披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800013857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662039279","title":"泰林生物（300813）2026年中报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2662039279","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662039279?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:46","pubTimestamp":1787870781,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期泰林生物发布2026年中报。截至本报告期末，公司营业总收入1.65亿元，同比上升13.41%，归母净利润2037.28万元，同比上升50.43%。本报告期泰林生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达336.31%。去年的净利率为4.8%，算上全部成本后，公司产品或服务的附加值不高。财报体检工具显示：建议关注公司应收账款状况本文数据来源于泰林生物2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800013173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662289367","title":"股市必读：泰林生物中报 - 第二季度单季净利润同比增长55.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662289367","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662289367?lang=zh_cn&edition=full","pubTime":"2026-08-27 06:43","pubTimestamp":1787784184,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘，泰林生物报收于20.5元，下跌1.2%，换手率3.39%，成交量2.58万手，成交额5384.36万元。股本股东变化：截至2026年6月30日股东户数为1.09万户，较3月31日减少30.1%，户均持股增至1.12万股。业绩披露要点：2026年第二季度单季度归母净利润1553.25万元，同比上升55.1%。关于2026年半年度报告披露的提示性公告2026年半年度报告已于2026年8月27日在巨潮资讯网披露。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700013115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662792823","title":"泰林生物(300813)6月30日股东户数1.09万户，较上期减少30.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662792823","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662792823?lang=zh_cn&edition=full","pubTime":"2026-08-26 17:48","pubTimestamp":1787737702,"startTime":"0","endTime":"0","summary":"证券之星消息，近日泰林生物披露，截至2026年6月30日公司股东户数为1.09万户，较3月31日减少4674.0户，减幅为30.1%。在专用设备行业个股中，泰林生物股东户数低于行业平均水平，截至6月30日，专用设备行业平均股东户数为2.94万户。从股价来看，2026年3月31日至2026年6月30日，泰林生物区间跌幅为34.03%，在此期间股东户数减少4674.0户，减幅为30.1%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600040317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662799591","title":"泰林生物(300813.SZ)发布上半年业绩，归母净利润2037.28万元，同比增长50.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662799591","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662799591?lang=zh_cn&edition=full","pubTime":"2026-08-26 16:45","pubTimestamp":1787733934,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰林生物(300813.SZ)发布2026年半年度报告，报告期内，公司实现营业收入1.65亿元，同比增长13.41%。实现归属于上市公司股东的净利润2037.28万元，同比增长50.43%。实现归属于上市公司股东的扣除非经常性损益的净利润1825.2万元，同比增长38.23%。拟向全体股东每10股派发现金红利1元(含税)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1485976.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"泰林生物(300813.SZ)发布上半年业绩，归母净利润2037.28万元，同比增长50.43%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660101211","title":"泰林生物终止发不超2.3亿可转债 为长城证券保荐项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2660101211","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660101211?lang=zh_cn&edition=full","pubTime":"2026-08-17 11:33","pubTimestamp":1786937589,"startTime":"0","endTime":"0","summary":"中国经济网北京8月17日讯 泰林生物 披露公告，公司于2026年8月14日召开第四届董事会第十五次会议，审议通过了《关于终止向不特定对象发行可转换公司债券并撤回申请文件的议案》，同意公司终止本次向不特定对象发行可转换公司债券并向深圳证券交易所申请撤回相关申请文件。 泰林生物表示，公司2025年度股东会已授权董事会全权办理本次发行可转换公司债券的全部事宜，本议案无需提交股东会审议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260817/32336724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0276","300813","002939","FCEF","SABA","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660705921","title":"股市必读：泰林生物新发布《关于终止向不特定对象发行可转换公司债券并撤回申请文件的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660705921","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660705921?lang=zh_cn&edition=full","pubTime":"2026-08-17 01:44","pubTimestamp":1786902254,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，泰林生物报收于20.48元，上涨1.14%，换手率6.7%，成交量5.1万手，成交额1.07亿元。公司公告汇总关于终止向不特定对象发行可转换公司债券并撤回申请文件的公告浙江泰林生物技术股份有限公司于2026年8月14日召开第四届董事会第十五次会议，审议通过终止向不特定对象发行可转换公司债券并撤回申请文件的议案。公司综合考虑实际情况和发展规划等因素，经与相关各方沟通后决定终止可转债发行并撤回申请文件。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700000624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658608150","title":"股市必读：泰林生物新发布《关于取得专利证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658608150","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658608150?lang=zh_cn&edition=full","pubTime":"2026-08-10 03:02","pubTimestamp":1786302135,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，泰林生物报收于19.98元，上涨2.57%，换手率2.81%，成交量2.14万手，成交额4186.4万元。当日关注点交易信息汇总：8月7日主力资金净流入58.0万元，占总成交额1.39%。公司公告汇总：全资子公司泰林医学工程取得一项放射性药物高精度自动混合分装装置发明专利，授权公告日为2026年8月4日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000001310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657364280","title":"泰林生物（300813）披露取得发明专利证书公告，8月7日股价上涨2.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657364280","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657364280?lang=zh_cn&edition=full","pubTime":"2026-08-07 22:40","pubTimestamp":1786113628,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，泰林生物报收于19.98元，较前一交易日上涨2.57%，最新总市值为24.22亿元。该股当日开盘19.42元，最高20.0元，最低19.12元，成交额达4186.4万元，换手率为2.81%。近日，浙江泰林生物技术股份有限公司全资子公司浙江泰林医学工程有限公司取得1项发明专利证书，专利名称为一种放射性药物的高精度自动混合分装装置及其分装方法，专利类型为发明，申请号2023118192043，授权公告日2026年8月4日，专利权人为泰林医学工程。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700041563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655800701","title":"股市必读：泰林生物（300813）新发布《关于取得专利证书及计算机软件著作权登记证书的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2655800701","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655800701?lang=zh_cn&edition=full","pubTime":"2026-07-31 02:56","pubTimestamp":1785437773,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，泰林生物报收于17.79元，下跌2.25%，换手率2.55%，成交量1.94万手，成交额3515.75万元。公司公告汇总关于取得专利证书及计算机软件著作权登记证书的公告浙江泰林生物技术股份有限公司全资子公司泰林生命科学取得2项发明专利和1项实用新型专利，泰林医学工程取得1项计算机软件著作权登记证书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100002000.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300813","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651748555","title":"股市必读：泰林生物（300813）7月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2651748555","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651748555?lang=zh_cn&edition=full","pubTime":"2026-07-15 02:32","pubTimestamp":1784053930,"startTime":"0","endTime":"0","summary":"截至2026年7月14日收盘，泰林生物报收于20.71元，下跌3.63%，换手率4.92%，成交量3.74万手，成交额7752.85万元。当日关注点交易信息汇总：7月14日主力资金净流出445.6万元，散户资金净流入1122.17万元。公司公告汇总：泰林生物全资子公司近期取得2项专利证书，含1项发明专利和1项实用新型专利，授权公告日均为2026年6月23日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500002827.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651203691","title":"泰林生物：TOC总有机碳分析仪可应用于超纯水","url":"https://stock-news.laohu8.com/highlight/detail?id=2651203691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651203691?lang=zh_cn&edition=full","pubTime":"2026-07-14 15:09","pubTimestamp":1784012954,"startTime":"0","endTime":"0","summary":"证券之星消息，泰林生物(300813)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问：公司在半导体级超纯水质检测有哪些应用与产品？泰林生物回复：您好，公司有机物分析系列的TOC总有机碳分析仪可应用于超纯水、制药用水、天然水体、饮用水、环保污水、化工工艺用水的水质分析与检测，其中超纯水方面的应用主要是超纯水的生产环节、废水回用前的检测环节。公司有机物分析系列产品目前主要还是应用于制药用水等领域，在公司整体营收中占比低于10%，在超纯水方面的应用占整体营收的比重低于1%，对公司经营业绩影响不大。谢谢关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400022809.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300813"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651127156","title":"泰林生物不超2.3亿元可转债被暂缓审议 长城证券保荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2651127156","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651127156?lang=zh_cn&edition=full","pubTime":"2026-07-14 14:48","pubTimestamp":1784011686,"startTime":"0","endTime":"0","summary":"中国经济网北京7月14日讯 深交所上市审核委员会2026 年第42 次审议会议于昨日召开，审议结果显示，浙江泰林生物技术股份有限公司 向不特定对象发行可转债暂缓审议。 泰林生物本次的保荐机构为长城证券股份有限公司，保荐代表人严绍东、白毅敏。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202607/14/20260714489719.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202607/14/20260714489719.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260714/32306808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0276","FCEF","300813","002939","BK0251","SABA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791455172814,"stockEarnings":[{"period":"1week","weight":-0.0164},{"period":"1month","weight":0.0893},{"period":"3month","weight":0.1488},{"period":"6month","weight":-0.1481},{"period":"1year","weight":-0.3714},{"period":"ytd","weight":-0.0656}],"compareEarnings":[{"period":"1week","weight":-0.024},{"period":"1month","weight":-0.0362},{"period":"3month","weight":-0.0463},{"period":"6month","weight":-0.0098},{"period":"1year","weight":-0.0105},{"period":"ytd","weight":-0.0319}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江泰林生物技术股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"10852人(较上一季度减少30.10%)","perCapita":"7844股","listingDate":"2020-01-14","address":"浙江省杭州市滨江区南环路2930号","registeredCapital":"12119万元","survey":" 浙江泰林生物技术股份有限公司的主营业务是无菌生产与污染控制设备、微生物检测及有机物分析等产品的研发、生产和销售。公司的主要产品是无菌生产与污染控制设备系列产品、微生物检测技术系列产品、有机物分析技术系列产品。","listedPrice":18.35},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰林生物(300813)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰林生物(300813)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰林生物,300813,泰林生物股票,泰林生物股票老虎,泰林生物股票老虎国际,泰林生物行情,泰林生物股票行情,泰林生物股价,泰林生物股市,泰林生物股票价格,泰林生物股票交易,泰林生物股票购买,泰林生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰林生物(300813)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰林生物(300813)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}